Prognostic Impact of Sleep Disordered Breathing and Its Treatment in Heart Failure: An Observational Study

Abstract

The presence of severe SDB in CHF patients constitutes a significantly increased risk for death, independent of established risk factors. In CHF patients with SDB, use of PAP therapy was associated with a decreased mortality rate at any time point of the follow-up, suggesting that PAP can be safely used in such patients.